Evolving Biomarkers for Ovarian Cancer Prognostication
Received Date: Dec 01, 2025 / Published Date: Dec 29, 2025
Abstract
Prognostic markers are crucial for predicting patient outcomes and guiding treatment in ovarian cancer. Current research focuses on a wide array of biomarkers including traditional ones like CA-125, alongside emerging molecular signatures, circulating tumor DNA, microRNAs, and protein-based markers. The tumor microenvironment, genomic alterations, circulating tumor cells, and epigenetic modifications are also investigated for their prognostic value. Furthermore, immune evasion pathways are critical for predicting response to immunotherapy. The development of multi-omic prognostic signatures and refined histopathological assessments are advancing personalized medicine in ovarian cancer management, aiming to improve survival and quality of life.
Citation: Bennett DL (2025) Evolving Biomarkers for Ovarian Cancer Prognostication. Current Trends Gynecol Oncol 10: 302.
Copyright: 漏 2025 Dr. Lucy Bennett This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.
Select your language of interest to view the total content in your interested language
Share This Article
Recommended Journals
Open Access Journals
Article Usage
- Total views: 224
- [From(publication date): 0-0 - Apr 22, 2026]
- Breakdown by view type
- HTML page views: 160
- PDF downloads: 64
